Harmony Biosciences Holdings, Inc.
HRMY
$38.05
$0.882.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.74% | 20.62% | 22.80% | 25.83% | 31.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.74% | 20.62% | 22.80% | 25.83% | 31.52% |
| Cost of Revenue | 23.88% | 26.09% | 29.35% | 38.67% | 41.25% |
| Gross Profit | 16.15% | 19.19% | 21.08% | 22.74% | 29.22% |
| SG&A Expenses | 13.96% | 14.60% | 14.83% | 20.87% | 17.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.20% | 32.85% | 34.34% | 47.92% | 35.79% |
| Operating Income | 24.58% | -4.22% | -0.63% | -12.11% | 21.29% |
| Income Before Tax | 36.45% | 5.23% | 10.62% | -1.39% | 23.18% |
| Income Tax Expenses | -11.54% | -10.51% | 3.97% | 94.84% | 175.43% |
| Earnings from Continuing Operations | 57.32% | 10.91% | 12.91% | -18.66% | -42.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 57.32% | 10.91% | 12.91% | -18.66% | -42.57% |
| EBIT | 24.58% | -4.22% | -0.63% | -12.11% | 21.29% |
| EBITDA | 21.35% | -3.97% | -0.67% | -10.81% | 18.35% |
| EPS Basic | 59.96% | 14.08% | 18.12% | -14.96% | -41.23% |
| Normalized Basic EPS | 31.12% | 2.96% | 9.54% | -2.24% | 33.87% |
| EPS Diluted | 59.14% | 13.50% | 18.49% | -14.34% | -40.46% |
| Normalized Diluted EPS | 30.20% | 2.24% | 9.17% | -1.74% | 35.47% |
| Average Basic Shares Outstanding | -1.30% | -2.92% | -4.35% | -4.30% | -2.79% |
| Average Diluted Shares Outstanding | -0.60% | -2.31% | -4.16% | -4.98% | -4.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |